Silverarc Capital Management’s VYNE Therapeutics VYNE Stock Holding History

Silverarc Capital Management’s Portfolio VYNE Stock Details VYNE Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell
2024 Q3	$144K	Sell
2024 Q2	$921K	Buy
2024 Q1	$265K	Buy
2021 Q1	–	Sell
2020 Q4	$552K	Buy